Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
NCT01871376
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG:
Intravitreal aflibercept injection 2.0mg
Sponsor
Gregg T. Kokame, MD
Collaborators
[object Object]